Investors should exit Astrazeneca on immediate basis: Seshadri Bharathan

In an exclusive interview with ET Now, Seshadri Bharathan, MD & CEO, KSEMA Fincon Ltd, talks about Astrazeneca.

In an exclusive interview with ET Now, Seshadri Bharathan, MD & CEO, KSEMA Fincon Ltd, talks about Astrazeneca. Excerpts:

Astrazeneca, on the stock what is the call?

90% of the stock is with the promoters and the offer price is band between 576 to 1152 and even if you look at last 6 months average price of Rs900 and you put a premium of 20% on that works out to around Rs1100 so if an investor is holding on to the stock should exit the stock on immediate basis.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

Related Companies

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Investors should exit Astrazeneca on immediate basis: Seshadri Bharathan
Text Size:AAA
Success
This article has been saved

*

+